Sorafenib did not extend time to progression in advanced HCC after transarterial chemoembolization | HemOncToday
Links shared publicly online about this topic.
- 1,433total visits
Sorafenib did not extend time to progression in advanced HCC after transarterial chemoembolization | HemOncToday
2010 Gastrointestinal Cancers Symposium </P
View full resource at hemonctoday.com
Tags: Gastroenterology, Cancer
Most Recently Shared on January 24, 2010 at 6:40 pm By:
#ASCO GI Late-breaker Sorafenib did not extend time to progression in advanced HCC after transarterial chemoembolization http://ow.ly/ZTeN
Also Shared By:
Advertisement
Dr Steven Tucker
@drsteventucker
RT @HemOncToday: #ASCO GI Sorafenib did not extend TTP in adv. HCC after chemoembolization http://ow.ly/ZTeA #HCC #cancer
1 year ago...